Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Cardioprotection for Acute MI in Light of the CONDI2/ERIC-PPCI Trial: New Targets Needed
Author(s): Joel P Giblett , Heerajnarain Bulluck Added: 3 years ago
The translation to clinical practice of agents or techniques that protect against the effect of ischaemia–reperfusion (IR) injury remains one of the most challenging areas of research in the field of cardiovascular medicine.1–4 This is particularly the case when IR injury follows revascularisation for acute MI (AMI). The publication of the combined Effect of Remote Ischaemic Conditioning on… View more

MI/ACS

Intervention
Summary of Presentations Exploring Other Aims of the A-CURE Group
Added: 6 years ago
Primary Left Ventricular Unloading and the Mechanical Conditioning Hypothesis
Author(s): Navin K Kapur Added: 6 years ago

Heart Failure
Revascularisation for Ischaemic Cardiomyopathy
Author(s): Matthew E Li Kam Wa , Saba Z Assar , Ajay J Kirtane , et al Added: 8 months ago

Vascular Disease and Surgery

Heart Failure
Author(s): Lija Swain Added: 3 years ago

Heart Failure

MI/ACS
Impaired Diastolic Function Predicts Improved Ischaemic Myocardial Flow Improvement with Mechanical Left Ventricular Unloading
Author(s): Tomoki Sakata Added: 1 year ago

Heart Failure
PCI for Ischemic Left Ventricular Dysfunction in 2023
Author(s): Angela Hoye , Rodney H Stables , Anthony Mathur , et al Added: 1 year ago
BCIS ACI 2023­ – Dr Angela Hoye (Hull & East Yorkshire Hospitals, UK), is joined by Dr Rod Stables (Liverpool Heart and Chest Hospital, UK), Dr Anthony Mathur (Barts Health NHS Trust, UK) and Dr Sen Devadathan (Royal Cornwall Hospitals NHS Trust, UK) to have a critical discussion on the BCIS-REVIVED trial and what it means for patients with ischemic left ventricular dysfunction in 2023. Data… View more

Heart Failure

Intervention
Author(s): P Sridhar , M Hedrick , T Baker , et al Added: 3 years ago
Abstract Adipose-derived regenerative cells (ADRCs) continue to be evaluated for use in the treatment of patients with chronic heart failure, particularly in those refractory to, or not suitable for, currently available options. This population of cells has demonstrated the ability to facilitate wound repair through the restoration of blood flow in ischaemic conditions, reduction in inflammation… View more

Vascular Disease and Surgery

Heart Failure
Sudden Cardiac Death in Ischaemic Cardiomyopathy
Author(s): Saad M Ezad , Girish Babu , Peter O’Kane Added: 1 year ago

Heart Failure

Electrophysiology & Arrhythmia
Cardiologists and Stroke Thrombectomy
Author(s): Helen Routledge , Andrew SP Sharp , Jan Kovac , et al Added: 1 year ago

Standards & Guidelines

Intervention